New Key Statistics Module, Z-Score and F-Score
OTCPK:GSGTF Key Ratios
| Market Cap $ M | 32.49 |
| Enterprise Value $ M | 44.13 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 52.79 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.38 |
| Beneish M-Score | -4.06 |
| 10-y EBITDA Growth Rate % | -0.80 |
| 5-y EBITDA Growth Rate % | 20.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.66 |
| EV-to-EBITDA | -3.00 |
| PEG | -- |
| Shares Outstanding M | 101.53 |
| Net Margin (%) | -2,500.75 |
| Operating Margin % | -2,487.94 |
| Pre-tax Margin (%) | -2,500.12 |
| Quick Ratio | 0.77 |
| Current Ratio | 0.77 |
| ROA % (ttm) | -147.66 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -118.10 |
| Dividend Yield % | -- |
| Altman Z-Score | -14.12 |
GSGTF Number of Guru Trades
GSGTF Volume of Guru Trades
Gurus Latest Trades with OTCPK:GSGTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:GSGTF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Gensight Biologics SA Insider Transactions
No Available Data
News about OTCPK:GSGTF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers